Literature DB >> 8472339

Specificity of mutations induced by N-methyl-N-nitrosourea in a cDNA of the hprt gene.

T Akagi1, K Hiromatsu, H Iyehara-Ogawa, H Kimura, T Kato.   

Abstract

N-Methyl-N-nitrosourea (MNU) reacts with DNA to produce a variety of lesions, of which O6-methylguanine (O6-MeG) has been implicated in the mutagenic and carcinogenic effects of this agent. The present study aimed to investigate the types and position specificities of mutations induced by MNU. Mutational sequence alterations were determined for 53 independent mutations induced by MNU in a cDNA of the human hprt gene, which is stably integrated into chromosomes of the mouse cell line VH12. The majority of the mutations induced by MNU were base substitutions (85%), mostly GC to AT transitions (41/43), and the remainder (15%) were frameshift or deletion mutations resulting from loss or addition of a few bases. The transition mutations occurred preferentially at the middle G in 5'-purine-G-N-3' sequences in the non-transcribed strand, and were distributed nonrandomly over the coding region of the gene. Analysis of the results suggests that, when interpreting mutational specificity and distribution, not only the nature of the mutational target sequence, but also the functional domains of the protein should be considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8472339     DOI: 10.1093/carcin/14.4.725

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  2 in total

1.  Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent.

Authors:  S E Andrew; M McKinnon; B S Cheng; A Francis; J Penney; A H Reitmair; T W Mak; F R Jirik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

2.  Different mutation frequencies and spectra among organs by N-methyl-N-nitrosourea in rpsL (strA) transgenic mice.

Authors:  Y Shioyama; Y Gondo; K Nakao; M Katsuki
Journal:  Jpn J Cancer Res       Date:  2000-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.